epi-506
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2015 (NCT02606123)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Androgen ReceptorINHIBITOR
AR inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- epi-506
- epi-506
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02606123 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2015 | British Columbia Cancer Agency, ESSA Pharmaceuticals, University of Washington |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| British Columbia Cancer Agency | Academic/Hospital | 1 | 0 | 1 | 2015 |
| ESSA Pharmaceuticals | For profit | 1 | 1 | 1 | 2015 |
| University of Washington | Academic/Hospital | 1 | 0 | 1 | 2015 |
3 organizations
Page 1 / 1